NAD(P)H: Quinone Oxidoreductase 1 Activatable Toll-Like Receptor 7/8 Agonist Designed for Precise Immunotherapy

Guo Li,Yongxiao Xu,Xiaojie Kong,Liuwei Gu,Yuling Qin,Li Wu
DOI: https://doi.org/10.1039/d3cc00663h
IF: 4.9
2023-01-01
Chemical Communications
Abstract:An NQO1-responsive precursor, named R848-QPA, has been developed to evoke an anti-tumor immune response. R848-QPA can induce innate immune activation when activated by overexpressed NQO1 in the tumor microenvironment while showing lower activity in NQO1-deprived environments. This strategy provides a new method for the development of tumor-microenvironment-responsive prodrugs for antitumor immunotherapy.
What problem does this paper attempt to address?